Course Description
All pharmacy practitioners are leaders in that we are all change agents and influencers of the thinking of our patients, students, and colleagues. Dr. Wells’ presentation is designed to help you select strategies to maximize your ability to bring about change in your professional setting and realize your potential to build programs, improve the care of patients, and increase your personal effectiveness.
Dr. Wells will not provide an overview of the fundamentals of leadership, but instead offer some leadership lessons learned over the course of her career as a psychiatric pharmacist, pharmacy educator, clinical scientist, department chair, and dean. She will discuss the importance of leadership communications, communicating “upward,” mentoring, and providing inspiration. She will talk about listening, being consistent, and persevering. Additionally, she will address building relationships and the role of trust and credibility. She will talk about why leaders must always take the high road and the necessity of finding meaning in one’s work in order to sustain the leadership effort.
Learning Objectives
- Identify leadership strategies to enhance goal accomplishment and personal effectiveness.
- Identify leadership behaviors that help others reach their full potential.
- Discuss the importance of leadership communication.
- Identify leadership strategies to effect change and build programs.
Faculty
View biographical information
Barbara G. Wells, PharmD, FCCP, BCPP
Dean Emeritus (Retired)
The University of Mississippi School of Pharmacy
Dr. Wells is Dean Emerita and Professor Emerita at The University of Mississippi School of Pharmacy and Executive Director Emerita of the Research Institute of Pharmaceutical Sciences. She earned her B.S.Ph. and Doctor of Pharmacy degrees at the University of Tennessee and completed a residency in psychiatric pharmacy at the University of Tennessee and Memphis Mental Health Institute. Dr. Wells was on the faculty at her alma mater for thirteen years, where she served as Vice Chairman of the Department of Clinical Pharmacy and Director of Mental Health Pharmacy Programs. Subsequently she served Samford University School of Pharmacy as Chairman of the Department of Pharmacy Practice and Idaho State University as Dean of the College of Pharmacy.
Dr. Wells has served as President and Chair of the Board of Directors of the American Association of Colleges of Pharmacy (AACP), President and Chair of the Board of Regents of the American College of Clinical Pharmacy (ACCP), Vice chair of the Board of Trustees of the ACCP Research Institute, member of the NIH Advisory Committee on Research on Women’s Health, member of the Psychopharmacologic Drugs Advisory Panel of the FDA, member of the Board of Directors of the American Foundation for Pharmaceutical Education, Vice Chair of the Commission on Credentialing of the American Society of Health-System Pharmacists (ASHP), Chair of the Council of Deans of AACP, Chair of the Section of Teachers of Pharmacy Practice of AACP, chair of the Argus Commission within AACP, Chair of the Board of Pharmacy Specialties (BPS), and member of the Specialty Council on Psychiatric Pharmacy within BPS. She is a fellow of ACCP and ASHP and a board certified Psychiatric Pharmacist.
Dr. Wells, whose primary instructional interests are in psychiatric therapeutics, has received seven teaching awards. She is a recipient of the Robert G. Leonard Lecture Award from the University of Texas College of Pharmacy and the Texas Society of Health-System Pharmacists, the Judith Saklad Memorial Lecture Award from the College of Psychiatric and Neurologic Pharmacists (CPNP), the Clinical Pharmacotherapeutic Practice Award from the American Pharmacists Association (APhA), the Education Award from ACCP, the Robert K. Chalmers Distinguished Pharmacy Educator Award from AACP, the Dean’s Award presented by the American College of Apothecaries, the Gloria Niemeyer Francke Leadership Mentor Award from APhA, and the Career Achievement Award from CPNP Foundation. She is a member of the National Academy of Practice of Pharmacy within the National Academies of Practice, the Mississippi Pharmacists Association Hall of Fame, and a co-editor of Pharmacotherapy: A Pathophysiologic Approach, Pharmacotherapy Handbook, and Pharmacotherapy Principles and Practice.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Date: 04/30/2012
ACPE Contact Hours: 1
ACPE Number: 0284-9999-12-005-L04-P (Knowledge)
ACCME:1 AMA PRA Category 1 Credit(s)™
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
ACPE Credit
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012 Annual Meeting will provide up to 14 contact hours (1.4 CEUs) of knowledge- and application-based continuing education credit from CPNP approved programming. The pre-meeting workshop is provided for an additional 7 contact hours (0.7 CEUs) and when combined with all other CPNP programming, allows for a maximum achievable 18 contact hours (1.8 CEUs). Industry supported symposia offered at the Annual Meeting offer additional ACPE credit.
To receive a statement of credit, participants must verify their attendance at the programming and complete evaluations and self-assessment questions. ACPE statements of credit will be retrieved by participants online on the CPNP website within one month following the event.
CME Credit
Sponsored by the University of Arizona College of Medicine at the Arizona Health Sciences Center.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint sponsorship of The University of Arizona College of Medicine at the Arizona Health Sciences Center and the College of Psychiatric and Neurologic Pharmacists. The University of Arizona College of Medicine at the Arizona Health Sciences Center is accredited by the ACCME to provide continuing medical education for physicians.
The University of Arizona College of Medicine at the Arizona Health Sciences Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
ACPE and ACCME approved contact hours are accepted for ANCC Certification Renewal (as quoted on the ANCC website): “Other health disciplines' continuing education hours may be used if the content is applicable to your area of certification. ACPE and ACCME are specifically listed as approved credit types.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patientâs conditions and possible contraindications on dangers in use, review of any applicable manufacturerâs product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.